Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
Giacomo Malipiero, Pierlanfranco D’Agaro, Ludovica Segat, Anna Moratto, Danilo Villalta
Topics & Concepts
Neutralizing antibodyTiterVaccinationMedicineNeutralizationAntibodyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immunoglobulin GVirologyImmunologyInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisPeripheral Neuropathies and Disorders